Oklahoma City-based Oncology Data Systems has struck a nonexclusive distribution agreement with Varian Medical Systems to provide independent monitor unit validation software to radiation oncology clinics. The products can be used to validate
Oklahoma City-based Oncology Data Systems has struck a nonexclusive distribution agreement with Varian Medical Systems to provide independent monitor unit validation software to radiation oncology clinics. The products can be used to validate calculations made by Varian's radiation oncology treatment planning software. Such verification is legally mandated. These products can help clinics automate the independent verification that they must put in place, according to Oncology Data Systems. MuCheck verifies 2D and 3D treatment plans. IMRT Check verifies IMRT treatment plans. Both are compatible with Varian's Eclipse and Helios treatment planning software products.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.